Sanofi India Limited — Updates, 16-07-2025: Press Release

Sanofi India has appointed Mr. Rachid Ayari, its current CFO, as Interim Managing Director for a six-month term, pending shareholder approval, addressing leadership transition. Mr. Aniket Raje was also appointed Head of Regulatory Affairs. Importantly, Sanofi India formed an exclusive five-year distribution partnership with Emcure Pharmaceuticals for its oral anti-diabetic brands, Amaryl® and Cetapin®. Sanofi will continue manufacturing these products, while Emcure will expand their market reach across India. This strategic alliance aims to significantly boost the accessibility, growth potential, and market penetration of Sanofi’s diabetes portfolio.